Title : Investigating healthcare inequalities in pancreatic cancer: Insights from the global burden of disease study in low-sdi nations
Abstract:
Pancreatic cancer represents a significant global health challenge, particularly in regions with low sociodemographic indices (SDI). This investigation leverages data from the Global Burden of Disease (GBD) study to analyze the prevalence, mortality, and disability-adjusted life years (DALYs) pertinent to pancreatic cancer in low-SDI locales. The insidious nature of pancreatic cancer, characterized by non-specific clinical manifestations, frequently results in delayed diagnosis, exacerbating the disparities experienced in these areas. The analysis reveals an escalating incidence of pancreatic cancer in low-SDI countries and delves into potential etiological contributors, such as genetic predispositions, lifestyle factors, and environmental exposures. It accentuates the necessity to comprehend the distinctive challenges confronting low-SDI countries, encompassing inadequate screening infrastructure, restricted resources, and insufficient disease awareness. Furthermore, the study addresses the disparities in healthcare access and outcomes that contribute to elevated morbidity and mortality rates in these regions. The mounting burden of pancreatic cancer in low-SDI countries, as evidenced by GBD data, calls for more extensive research to elucidate the intricate interplay of risk factors and to devise targeted prevention and intervention approaches. The enhancement of screening programs, heightened public awareness, and equitable healthcare resource allocation are vital to mitigating disparities in pancreatic cancer outcomes and alleviating the disease burden in low-SDI countries. This rigorous examination of GBD data underscores the urgency to confront healthcare disparities in pancreatic cancer and refine diagnostic and therapeutic strategies in low-SDI settings.
Audience Take Away:
1.The presentation will help raise awareness about the increasing trend of pancreatic cancer in low SDI countries. By drawing attention to this issue, international stakeholders, healthcare professionals, and policymakers may be more motivated to prioritize pancreatic cancer research, prevention, and treatment efforts in these regions.
2.The presentation highlights the need for tailored prevention and intervention strategies to address the complex interplay of risk factors contributing to the rising incidence of pancreatic cancer in low SDI countries. By emphasizing the role of improved screening programs, increased public awareness, and equitable access to healthcare resources, the audience will recognize the importance of implementing context-specific approaches to reduce the pancreatic cancer burden and address disparities in low SDI countries.
3.The audience will gain insights into the diagnosis of pancreatic cancer, a condition with vague clinical manifestation yet contributed significant mortality to patient especially country with low socioeconomic status.
